Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (3.694.634 €): Multimodale optische Diagnostik bei Augen- und Neurodegenerativen Erkrankungen Hor 01.11.2016 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Multimodale optische Diagnostik bei Augen- und Neurodegenerativen Erkrankungen
The rising life expectancy of EU citizens is creating a dramatic increase in age-related degenerative diseases and associated healthcare costs. The MOON Project (Multi-modal Optical Diagnostics for Ocular and Neurodegenerative Disease) meets this societal challenge by applying photonics to diagnose age-related diseases of the eye and central nervous system. Consistent with the ICT-29-2016: Photonics KET 2016 Work Program, MOON will design and build a multi-band, multimodal and functional imaging platform combining label-free molecularly sensitive Raman spectroscopy with high speed and high-resolution Optical Coherence Tomography (OCT), for in-depth diagnostics of ocular and neurodegenerative diseases. MOON will enhance OCT – already the gold standard of retinal imaging - through the development of a disruptive laser technology that enables wide-field structural and functional imaging. MOON will establish a reference database for molecular biomarkers of addressed diseases that enables, for the first time, in-depth molecular-specific diagnosis of retinal diseases and neurodegenerative pathologies based on Raman spectroscopy. The MOON system will be validated in vivo in a clinical setting through close collaboration between clinicians and commercial partners. The clinical validation will establish the diagnostic accuracy of the multi-modal platform, while also verifying the ease-of-use needed for widespread adoption. MOON is driven by unmet medical user needs in diagnostic imaging with a clear business case addressing the highly promising ophthalmic market of early and in-depth molecularly sensitive diagnostics of retinal and neurodegenerative diseases. The three industrial partners cover the complete value/supply chain. MOON aims to bridge the gap between research and product development, thereby expediting the commercialization of the MOON technologies, strengthening the participating companies, and creating a competitive advantage for the European photonics market.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Carl Zeiss AG | 680.620 € |
| Horiba France SAS | 512.500 € |
| Innolume GmbH | 594.500 € |
| Leibniz-Institut Fuer Photonische Technologien e. V. | 583.500 € |
| Medizinische Universitaet Wien | 812.702 € |
| Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNO | 510.812 € |
Quelle: https://cordis.europa.eu/project/id/732969
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.